Skip to main content
Clinical Trials/JPRN-UMIN000002477
JPRN-UMIN000002477
Completed
未知

Drug-drug interaction study to explore importance of CYP3A4 and OATP1B1 as factors determining pharmacokinetics of atorvastatin - Drug-drug interaction study on atorvastatin

Clinical trial Center,Kitsato University East Hospital0 sites8 target enrollmentStarted: September 10, 2009Last updated:

Overview

Phase
未知
Status
Completed
Sponsor
Clinical trial Center,Kitsato University East Hospital
Enrollment
8

Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
20years-old to 40years-old (—)
Sex
Male

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\)Any hypersensitivities to atorvastatin,midazolam,pravastatin, straconazole or rifampicin. 2\)hepatic disease requiring treatment. 3\)acute narrow\-angle glaucoma 4\)QT prolongation over 460ms. 5\)Use of medicine or health product including Saint John's wort 2 weeks before pre\-dose. 6\)Intake of fruit food and drink including grapefruit juice, orange juice or apple juice from 7 days before pre\-dose. 7\)Participation to any other clinical reseach in the past 3 months. 8\)Donating over 200 ml of blood in the past 1 month or over 400ml of blood in the past 3 months. 9\)Positive tests of serological reaction for syphilis, HIV antigen and antibody, HBs antigen or HCV antibody. 10\)Any allergy to drug and food 11\)Drug abuse or positive drug screening 12\)Any condition that, in the opinion of the investigator, would make the patient unsuitable for the study.

Investigators

Sponsor
Clinical trial Center,Kitsato University East Hospital

Similar Trials